The TrueScreen commercialisation project is dedicated to developing a non-invasive, urine-based diagnostic solution for urological cancers, especially prostate cancer. Current diagnostic methods ...

An AI tool may spot prostate cancer with 84% accuracy, according to a UCLA research, outperforming doctors who had a 67% accuracy rate. Unfold AI, an AI program created by Avenda Health ...

Goodbye, flop era! Prostate cancer is the most common cancer among men in the US, aside from skin cancer. About 13% of male Americans will get it — and treatment often comes with the risk of erectile ...

A web-based digital tool called Helix could help clinicians identify patients with prostate cancer who would benefit from genetic testing and counselling, according to researchers in the US.

09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic test continues to be ...